US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class II · Moderate risk Terminated

EPINEPHrine

Reason Lack of Assurance of Sterility

SterRx, LLC NDC 70324-027-01 D-0304-2022
Class II · Moderate risk Terminated

NOREPINEPHRINE 4 mg per 250 mL

Reason Lack of Assurance of Sterility

SterRx, LLC NDC 70324-451-01 D-0303-2022
Class II · Moderate risk Terminated

dilTIAZem HCl 125 mg per 125 mL

Reason Lack of Assurance of Sterility

SterRx, LLC NDC 70324-976-01 D-0302-2022
Class III · Low risk Terminated

Fexofenadine HCl

Reason Failed dissolution specifications

Dr. Reddy's Laboratories, Inc. NDC 43598-823-31 D-0275-2022
Class III · Low risk Terminated

Allergy Relief D Fexofenadine HCl

Reason Failed dissolution specifications

Dr. Reddy's Laboratories, Inc. NDC 49035-273-30 D-0274-2022
Class III · Low risk Terminated

Allergy Relief D Fexofenadine HCl

Reason Failed dissolution specifications

Dr. Reddy's Laboratories, Inc. NDC 69842-249-30 D-0273-2022
Class III · Low risk Terminated

Antihistamine & Nasal Decongestant

Reason Failed dissolution specifications

Dr. Reddy's Laboratories, Inc. NDC 0638-1242-07 D-0271-2022
Class III · Low risk Terminated

Antihistamine & Nasal Decongestant

Reason Failed dissolution specifications

Dr. Reddy's Laboratories, Inc. NDC 0536-1242-34 D-0270-2022
Class II · Moderate risk Terminated

Buprenorphine HCl

Reason Crystallization; identified as Buprenorphine free base

PAR Sterile Products LLC D-0087-2024
Class II · Moderate risk Terminated

Hand Sanitizer Foam

Reason Defective Container: Customer complaints for leaking bottles and dispensing issues.

Medline Industries Inc NDC 53329-970-12 D-0287-2022
Class II · Moderate risk Terminated

Flocinolone Acetonide 0.01% Topical Oil

Reason Subpotent Drug: Out-of-specification assay result was obtained for Fluocinolone Acetonide.

Amneal Pharmaceuticals of New York, LLC NDC 65162-703-86 D-0234-2022
Class II · Moderate risk Terminated

Flocinolone Acetonide 0.01% Topical Oil

Reason Subpotent Drug: Out-of-specification assay result was obtained for Fluocinolone Acetonide.

Amneal Pharmaceuticals of New York, LLC NDC 65162-704-86 D-0233-2022
Class II · Moderate risk Terminated

Cefixime Capsules 400 mg

Reason Failed Impurities/Degradation Specifications

Ascend Laboratories LLC NDC 67877-584-50 D-0229-2022
Class II · Moderate risk Terminated

Acetaminophen Oral Suspension

Reason cGMP Deviations: Product manufactured with contaminated raw ingredient.

Precision Dose Inc. D-0095-2022